Certain Common Stock of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2023. These Common Stock will be under lockup for 60 days starting from 25-SEP-2023 to 24-NOV-2023.

Details:
Directors, officers and certain of stockholders have agreed with the underwriter, subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of common stock or securities convertible into or exercisable or exchangeable for common stock for a period of six months with respect to our directors, officers and certain of stockholders after the date of this prospectus.